Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis

BACKGROUND: Prophylactic anticoagulant therapy is recommended to reduce the risk of venous thromboembolism (VTE) after total hip or knee arthroplasty, and has become the standard of care. Rivaroxaban is a novel oral medication that directly inhibits factor Xa for the prevention and treatment of thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jichao, Zhao, Jinlong, Yan, Yong, Su, Jinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831257/
https://www.ncbi.nlm.nih.gov/pubmed/30817570
http://dx.doi.org/10.1097/MD.0000000000014539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831257/
https://www.ncbi.nlm.nih.gov/pubmed/30817570
http://dx.doi.org/10.1097/MD.0000000000014539

Ejemplares similares